Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Accelerating Research to Get Answers Faster

Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis

Physician-scientist Cyndy Grosskreutz explains why she transitioned from academia to industry.

Cardiovascular researcher Jennifer Allport-Anderson describes the personal qualities and decisions that have made her a successful leader.

Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.